These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6382505

  • 1. Mammary tumor heterogeneity.
    Heppner GH, Loveless SE, Miller FR, Mahoney KH, Fulton AM.
    Symp Fundam Cancer Res; 1983; 36():209-21. PubMed ID: 6382505
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Macrophage-tumor interaction induced by antibody in antibody-dependent, macrophage-mediated tumor lysis.
    Kurisu M, Dohi N, Yamazaki M, Mizuno D.
    J Reticuloendothel Soc; 1980 Sep; 28(3):237-48. PubMed ID: 7411539
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability.
    Miller FR, Miller BE, Heppner GH.
    Invasion Metastasis; 1983 Sep; 3(1):22-31. PubMed ID: 6677618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
    Welch DR, Aeed PA, Earhart RH, McClure SA.
    Anticancer Res; 1994 Sep; 14(5A):1743-51. PubMed ID: 7847807
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of tumour and normal cells to the effect of immune lymphocytes in vitro and some properties of target cells determing this sensitivity.
    Lavrovsky VA, Razvorotnev VA.
    Folia Biol (Praha); 1976 Sep; 22(2):108-15. PubMed ID: 776718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
    Lopez DM, Sigel MM.
    J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Macrophage production by the bone marrow of tumor-bearing mice.
    Baum M, Fisher B.
    Cancer Res; 1972 Dec; 32(12):2813-7. PubMed ID: 4644210
    [No Abstract] [Full Text] [Related]

  • 13. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
    Loveless SE, Heppner GH.
    J Immunol; 1983 Oct; 131(4):2074-8. PubMed ID: 6619548
    [Abstract] [Full Text] [Related]

  • 14. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M, Musiani P, Garotta G, Ebner R, Di Carlo E, Kim Y, Cappello P, Rigamonti L, Bernabei P, Novelli F, Modesti A, Coletti A, Ferrie AK, Lollini PL, Ruben S, Salcedo T, Forni G.
    J Immunol; 1999 Nov 01; 163(9):4886-93. PubMed ID: 10528190
    [Abstract] [Full Text] [Related]

  • 15. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
    Watson GA, Lopez DM.
    J Immunol; 1995 Sep 15; 155(6):3124-34. PubMed ID: 7673727
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
    Lord EM.
    Br J Cancer Suppl; 1980 Apr 15; 4():123-7. PubMed ID: 6932915
    [Abstract] [Full Text] [Related]

  • 18. Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.
    Fisher B, Hanlon JT, Linta J, Saffer E.
    Cancer Res; 1977 Oct 15; 37(10):3628-33. PubMed ID: 908011
    [No Abstract] [Full Text] [Related]

  • 19. Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression.
    Wei WZ, Gill RF, Wang H.
    Semin Cancer Biol; 1993 Jun 15; 4(3):205-13. PubMed ID: 8391342
    [Abstract] [Full Text] [Related]

  • 20. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB, Ketcham AS, Hammond WG.
    Laryngoscope; 1973 Mar 15; 83(3):376-87. PubMed ID: 4690029
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.